Lupin Gets US FDA Tentative Approval for Apixaban Suspension
Lupin has received tentative US FDA approval for Apixaban Oral Suspension 1.25 mg/mL, offering an alternative anticoagulation option for adults who may have swallowing difficulties.
Lupin US FDA Tentative Approval | 29/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy